List of Excipients in API HALOBETASOL PROPIONATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HALOBETASOL PROPIONATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER COPOLYMER TYPE B | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER HOMOPOLYMER TYPE A | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | DIETHYL SEBACATE | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | EDETATE DISODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HALOBETASOL PROPIONATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | CETYL ALCOHOL |
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | DIAZOLIDINYL UREA |
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | GLYCERIN |
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 | ISOPROPYL ISOSTEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for HALOBETASOL PROPIONATE
Excipient focus: ALCOHOL
HALOBETASOL PROPIONATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 51862-618 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALLYL PENTAERYTHRITOL
HALOBETASOL PROPIONATE drug variants containing ALLYL PENTAERYTHRITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teligent Pharma Inc | halobetasol propionate | 52565-073 |
| McKesson Corporation | halobetasol propionate | 63739-998 |
| Sola Pharmaceuticals | halobetasol propionate ointment | 70512-033 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing ALLYL PENTAERYTHRITOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM STEARATE
HALOBETASOL PROPIONATE drug variants containing ALUMINUM STEARATE
HALOBETASOL PROPIONATE drug variants not containing ALUMINUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZOIC ACID
HALOBETASOL PROPIONATE drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 51862-618 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLPARABEN
HALOBETASOL PROPIONATE drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER COPOLYMER TYPE B
HALOBETASOL PROPIONATE drug variants containing CARBOMER COPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CARBOMER COPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE
HALOBETASOL PROPIONATE drug variants containing CARBOMER HOMOPOLYMER TYPE
| Company | Ingredient | NDC |
|---|---|---|
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CARBOMER HOMOPOLYMER TYPE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
HALOBETASOL PROPIONATE drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
HALOBETASOL PROPIONATE drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETETH-20
HALOBETASOL PROPIONATE drug variants containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
HALOBETASOL PROPIONATE drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 51862-618 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
HALOBETASOL PROPIONATE drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIAZOLIDINYL UREA
HALOBETASOL PROPIONATE drug variants containing DIAZOLIDINYL UREA
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| Rebel Distributors Corp | halobetasol propionate | 42254-250 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing DIAZOLIDINYL UREA
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYL SEBACATE
HALOBETASOL PROPIONATE drug variants containing DIETHYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing DIETHYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIISOPROPYL ADIPATE
HALOBETASOL PROPIONATE drug variants containing DIISOPROPYL ADIPATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing DIISOPROPYL ADIPATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
HALOBETASOL PROPIONATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
HALOBETASOL PROPIONATE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ISOSTEARATE
HALOBETASOL PROPIONATE drug variants containing ISOPROPYL ISOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1321 |
| Bryant Ranch Prepack | halobetasol propionate | 63629-8735 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing ISOPROPYL ISOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
HALOBETASOL PROPIONATE drug variants containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| Rebel Distributors Corp | halobetasol propionate | 42254-250 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
HALOBETASOL PROPIONATE drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLCHLOROISOTHIAZOLINONE
HALOBETASOL PROPIONATE drug variants containing METHYLCHLOROISOTHIAZOLINONE
HALOBETASOL PROPIONATE drug variants not containing METHYLCHLOROISOTHIAZOLINONE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLISOTHIAZOLINONE
HALOBETASOL PROPIONATE drug variants containing METHYLISOTHIAZOLINONE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| Rebel Distributors Corp | halobetasol propionate | 42254-250 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing METHYLISOTHIAZOLINONE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
HALOBETASOL PROPIONATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: MONOSTEARYL CITRATE
HALOBETASOL PROPIONATE drug variants containing MONOSTEARYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1322 |
| Teligent Pharma Inc | halobetasol propionate | 52565-073 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing MONOSTEARYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: OCTYLDODECANOL
HALOBETASOL PROPIONATE drug variants containing OCTYLDODECANOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing OCTYLDODECANOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: PENTAERYTHRITOL
HALOBETASOL PROPIONATE drug variants containing PENTAERYTHRITOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| QUAGEN PHARMACEUTICALS LLC | halobetasol propionate | 70752-119 |
| Bryant Ranch Prepack | halobetasol propionate | 72162-2067 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing PENTAERYTHRITOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
HALOBETASOL PROPIONATE drug variants containing PETROLATUM
HALOBETASOL PROPIONATE drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLAWAX POLYSORBATE
HALOBETASOL PROPIONATE drug variants containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 51862-618 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
HALOBETASOL PROPIONATE drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
HALOBETASOL PROPIONATE drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 51862-618 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
HALOBETASOL PROPIONATE drug variants containing PROPYLENE GLYCOL
HALOBETASOL PROPIONATE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
HALOBETASOL PROPIONATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
HALOBETASOL PROPIONATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOOLEATE
HALOBETASOL PROPIONATE drug variants containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN SESQUIOLEATE
HALOBETASOL PROPIONATE drug variants containing SORBITAN SESQUIOLEATE
HALOBETASOL PROPIONATE drug variants not containing SORBITAN SESQUIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
HALOBETASOL PROPIONATE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-21
HALOBETASOL PROPIONATE drug variants containing STEARETH-21
HALOBETASOL PROPIONATE drug variants not containing STEARETH-21
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
HALOBETASOL PROPIONATE drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Lacer Pharma LLC | halobetasol propionate | 73159-008 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
HALOBETASOL PROPIONATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing WATER
Excipient focus: WHITE WAX
HALOBETASOL PROPIONATE drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1322 |
| QUAGEN PHARMACEUTICALS LLC | halobetasol propionate | 70752-119 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0640 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0758 |
| >Company | >Ingredient | >NDC |
Excipient focus: YELLOW WAX
HALOBETASOL PROPIONATE drug variants containing YELLOW WAX
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | halobetasol propionate | 45802-131 |
| Teligent Pharma Inc | halobetasol propionate | 52565-073 |
| HJ Harkins Company Inc | halobetasol propionate | 52959-961 |
| Physicians Total Care Inc | halobetasol propionate | 54868-5482 |
| >Company | >Ingredient | >NDC |
HALOBETASOL PROPIONATE drug variants not containing YELLOW WAX
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0339 |
| Cosette Pharmaceuticals Inc | halobetasol propionate | 0713-0639 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
